KPPOCD: Ketamine Prevent POCD

Sponsor
RenJi Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT02220400
Collaborator
(none)
484
3
2
24
161.3
6.7

Study Details

Study Description

Brief Summary

Previous study demonstrated that neuroinflammation induced by surgery is the main cause of the postoperative cognitive dysfunction. As an agonist of NMDA receptor, ketamine is proved to be an anti-inflammation agent. In present study investigators hypothesized that low dose ketamine would prevent the cognition decline after orthopedic surgery in aged patients.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
484 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Low Dose Ketamine Prevent the Postoperative Cognitive Dysfunction in Aged Patients Underwent Orthopaedic Surgery,a Randomized Control Double Blinded Multicenter Clinical Trail
Study Start Date :
Sep 1, 2014
Anticipated Primary Completion Date :
Sep 1, 2016
Anticipated Study Completion Date :
Sep 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Ketamine

Ketamine infusion group

Drug: Ketamine

Placebo Comparator: Placebo

Normal saline infusion

Outcome Measures

Primary Outcome Measures

  1. Short-term cognitive changes after surgery [The day before surgery and 7 days after surgery (or before leave hospital)]

    Investigators would use mini-mental state examination(MMSE), Visual reproduction test,digit symbol,digit span,color trail test and Stroop color and word test for measuring the short-term cognitive changes of patients after surgery.

  2. Long-term cognitive changes after surgery [The day before surgery and 2 months after surgery]

    Investigators would use mini-mental state examination(MMSE), Visual reproduction test,digit symbol,digit span,color trail test and Stroop color and word test for measuring the long-term cognitive changes of patients after surgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Elder than 60

  • Easily communicated with Chinese

  • Selected to kneel or hip replacement

  • Agree to take part into this clinical trail

Exclusion Criteria:
  • Existing cerebral disease, or have a history of neurological and psychiatric disease including AD, stroke and psychosis

  • Existing cognitive impairment as evidenced by Mini-Mental State Examination scores below 24

  • Several audition or vision disorder

  • Preoperative systolic Blood pressure over 190mmHg or diastolic pressure >100mmHg

  • Existing a history of hyperthyroidism

  • Patient with glaucoma

  • Unwillingness to comply with the protocol or procedures

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shanghai Tongji Hospital Shanghai Shanghai China 200065
2 Renji Hospital, School of Medicine, Shanghai Jiaotong University Shanghai Shanghai China 200127
3 Shanghai Pudong New Area People's Hospital Shanghai Shanghai China

Sponsors and Collaborators

  • RenJi Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
diansan su, Dr., RenJi Hospital
ClinicalTrials.gov Identifier:
NCT02220400
Other Study ID Numbers:
  • KPPOCD
First Posted:
Aug 19, 2014
Last Update Posted:
Aug 19, 2014
Last Verified:
Aug 1, 2014

Study Results

No Results Posted as of Aug 19, 2014